Kazuto Nishio

Title: Kazuto Nishio: Innovator in Cancer Treatment

Introduction

Kazuto Nishio is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of cancer treatment, particularly in the development of methods that enhance the effectiveness of chemotherapy for colorectal cancer. With a total of 3 patents, his work focuses on utilizing biomarkers to improve treatment selection for patients.

Latest Patents

One of Nishio's latest patents is a treatment selection method and biomarker indicating selection for colorectal cancer. This invention addresses the challenge of determining the most effective chemotherapy regimen for patients in stage IV of the disease. By identifying a specific biomarker that indicates whether the FOLFOX or FOLFIRI regimen is more advantageous, his method provides a personalized approach to treatment. The biomarker is characterized by a gain in the copy number of specific regions on human chromosomes, which allows for better prediction of treatment efficacy.

Another notable patent involves a method or system using biomarkers for monitoring treatment activity. This invention relates to the monitoring of a compound known as 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone. It is particularly focused on its monoethanesulphonate salt form, which can be used alone or in combination with other treatments, such as radiotherapy.

Career Highlights

Kazuto Nishio has worked with several notable companies throughout his career. He has been associated with Boehringer Ingelheim International GmbH and Sumitomo Bakelite Company Limited. His experience in these organizations has contributed to his expertise in the pharmaceutical and biotechnology sectors.

Collaborations

Nishio has collaborated with several professionals in his field, including Tokuzo Arao and Kanae Kudo. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in cancer treatment.

Conclusion

Kazuto Nishio is a dedicated inventor whose work in cancer treatment has the potential to significantly improve patient outcomes. His innovative approaches to treatment selection and monitoring demonstrate his commitment to advancing medical science.